Evaluation of molecular descriptors for antitumor drugs with respect to noncovalent binding to DNA and antiproliferative activity.

The prediction of logKeq using these molecular descriptors was low 36% according to the r 2 values, corresponding to about 26% when an adjusted r 2 , which accounts for the small size of the sample, was used (AdR 2 in Table 4 ) and barely significant (Table 4 ).

also in 875 other papers